CORSAIR PHARMA INC has a total of 43 patent applications. It decreased the IP activity by 81.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are NABRIVA THERAPEUTICS AG, BYK NEDERLAND BV and ORIDIGM CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 23 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | Israel | 2 | |
#7 | Japan | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Acyclic or carbocyclic compounds | |
#3 | Heterocyclic compounds | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Xiaoming | 41 |
#2 | Becker Cyrus K | 37 |
#3 | Venkatraman Meenakshi S | 35 |
#4 | Rescourio Gwenaella | 7 |
#5 | Venkatraman Meenakshi | 4 |
#6 | Pfister Jürg | 4 |
#7 | Pfister Jürg R | 3 |
#8 | Meenakshi Venkatraman | 2 |
#9 | Juerg Pfister | 2 |
#10 | Gwenaella Rescourio | 2 |
Publication | Filing date | Title |
---|---|---|
JP2020011957A | Treprostinil derivative compound and method of using the same | |
US2019290597A1 | Dermal and transdermal administration of treprostinil and salts thereof | |
US2016368855A1 | Treprostinil derivatives and compositions and uses thereof | |
US9394227B1 | Treprostinil derivatives and compositions and uses thereof | |
WO2016010538A1 | Treprostinil derivative compounds and methods of using same | |
US2015166503A1 | Treprostinil derivative compounds and methods of using same | |
EP3712142A1 | Prodrugs of treprostinil |